Quotient Sciences
Nottingham, United Kingdom
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: Quotient Sciences
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Nottingham, United Kingdom
- Modalities
- Small Molecule (Oral Solid Dose), HPAPI / High-Potency API, Modified Release, Pediatric Formulation, Oral Peptide, Solubility Enhancement (SDD, HME, Nanoparticulate), Clinical Pharmacology (Phase I CRO)
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Quotient Sciences
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSmall Molecule (Oral Solid Dose), HPAPI / High-Potency API, Modified Release, Pediatric Formulation, Oral Peptide, Solubility Enhancement (SDD, HME, Nanoparticulate), Clinical Pharmacology (Phase I CRO)
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
Acquisitive Quotient buys CDMO Pharmaterials, reveals new identity - Fierce Biotech
Pharma in 2025–2026: AI, China and the new era of drug development - Manufacturing Chemist
Thierry Van Nieuwenhove Appointed as CEO of Quotient Sciences - CHEManager
Quotient Sciences and Biorasi partner to accelerate early phase clinical trials to patient proof-of-concept - PR Newswire
Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization - Business Wire
CEO Spotlight: Thierry Van Nieuwenhove - Contract Pharma
CDMO Roundtable: Managing Orphan Drug Projects - DCAT Value Chain Insights
Quotient Sciences casts $8.7M spell over its new Alnwick facility, adding drug substance capacity and 80 jobs - Fierce Pharma
CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos - Fierce Pharma
Quotient's streamlined drug development process saves months - Pharmaceutical Technology
Frequently Asked Questions About Quotient Sciences
What is Quotient Sciences's CDMO Signal Score?
Quotient Sciences has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Quotient Sciences for a manufacturing program?
Use the free AI matchmaker to compare Quotient Sciences against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Altasciences
Laval, Canada
Small Molecule (Oral Solid Dose), Capsules (liquid-filled, gelatin, hypromellose), HPAPI / High-Potency API, Formulation Development, Analytical & Stability Testing, Clinical Trial Material Manufacturing, Phase I–Commercial Scale Manufacturing
Bend Bioscience
Bend, OR
Spray Dried Dispersion (SDD), Amorphous Solid Dispersion (ASD), Particle Engineering, Oral Solid Dose, Multiparticulates, Modified Release, Small Molecule API
Serán Bioscience
Bend, OR
Small Molecule (Oral Solid Dose), Spray Dried Dispersion (SDD), Hot Melt Extrusion (HME), Nano-milling / Nanoparticulate, Fluid Bed Processing, Particle Engineering, Pulmonary / Inhaled Particulates, Nasal Drug Delivery, Finished Dose (tablets, capsules, OPCs, powder-in-bottle)
Bora Pharmaceuticals
Taipei, Taiwan
Small Molecule (Oral Solid Dose), Biologics (Drug Substance & Drug Product), Monoclonal Antibody, Sterile Injectables / Aseptic Fill-Finish, Semi-Solids (creams, ointments, gels), Liquids (solutions, suspensions, ophthalmics, nasal sprays), Lyophilization
Glatt Pharmaceutical Services
Binzen, Germany
Multiparticulate Systems, Pellets, Micropellets, Granules, Fluid Bed Coating, Wurster Coating, Spray Coating, Modified Release, Oral Solid Dose